TCL Archive FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight December 17, 2010
TCL Archive Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients November 27, 2009
TCL Archive Letter to the Editor: Could Managed care Cause Drop In Accrual In Suramin Trial? January 5, 1996
TCL Archive Waxman Compromise Bill Clears House; Centers Line Item Traded For Guarantee Of Minimum Number of 55 November 25, 1983
